IL1B and Alzheimer disease: As mentioned above, LRRFIP1 could have a certain therapeutic effect on AD by inhibiting TNF-α signaling whereas M1 macrophages are associated with the expression of classic inflammatory cytokines, such as IL-1β and TNFα (DeGregorio-Rocasolano et al., 2020).